Midtrimester triple-test levels in women with chronic hypertension and altered renal function

Prenatal Diagnosis

Volumn 23, Issue 2, 2003, Pages 166-167

  Shenhavl, Simon ^a   Gemer, Ofer ^a,c   Sherman, Dan J ^b   Peled, Ronit ^a   Segal, Shmuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Chronic hypertension; Midtrimester triple test; Renal function

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CREATININE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; CHRONIC DISEASE; CREATININE; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; PRENATAL DIAGNOSIS;

EID: 0037330242     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.564     Document Type: Article

References (12)

1. Bar J, Wittenberg C, Hod M, et al. 1996. Pregnancy outcome in renal allograft recipients in Israel. Isr J Med Sci 32: 1183-1185.
2. Bogart MH, Pandian MR, Jones OW. 1987. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 7: 623-630.
3. Cararach V, Casals E, Martinez S, et al. 1997. Abnormal renal function as a cause of false-positive biochemical screening for Down's syndrome. Lancet 350: 1295.
4. Cheng PJ, Liu CM, Chang SD, Lin YT, Soong YK. 1999. Elevated second-trimester maternal serum hCG in patients undergoing haemodialysis. Prenat Diagn 19: 955-958.
5. Clark F, Dickinson JE, Walters BN, Marshall LR, O'Leary PC. 1995. Elevated mid-trimester hCG and maternal lupus anticoagulant. Prenat Diagn 15: 1035-1039.
6. Fox H. 1970. Effect of hypoxia on trophoblast in organ culture. A morphologic and autoradiographic study. Am J Obstet Gynecol 107: 1058-1064.
7. Karidas CN, Michailidis GD, Spencer K, Economides DL. 2002. Biochemical screening for Down syndrome in pregnancies following renal transplantation. Prenat Diagn 22: 226-230.
8. Macri JN, Spencer K. 1996. Towards the optimal protocol for Down's syndrome screening. Am J Obstet Gynecol 174: 1668-1669.
9. Maymon R, Cuckle H, Shemi IK, Herman A, Sherman D. 2001. Maternal serum chorionic gonadotropin levels in systemic lupus erythematosus and antiphospholipid syndrome. Prenat Diagn 21: 143-145.
10. Salafia CM, Silberman L, Herrera NE, Mahoney MJ. 1988. Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration. Am J Obstet Gynecol 158: 1064-1068.
11. Meuris S, Nagy AM, Delogne-Desnoeck J, Jurkovic D, Jauniaux E. 1995. Temporal relationship between the human chorionic gonadotropin peak and the establishment of intervillous blood flow in early pregnancy. Hum Reprod 10: 947-950.
12. Wald N, Cuckle H. 1988. AFP and age screening for Down syndrome. Am J Med Genet 31: 197-209.